IQVIA Holdings Inc. (IQV)
USD 150.92
(3.69%)
USD 150.92
(3.69%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 12.85 Billion USD | 8.99% |
| 2022 | 11.79 Billion USD | 6.53% |
| 2021 | 11.07 Billion USD | -0.16% |
| 2020 | 11.09 Billion USD | -1.02% |
| 2019 | 11.2 Billion USD | 10.76% |
| 2018 | 10.11 Billion USD | 9.17% |
| 2017 | 9.26 Billion USD | 54.38% |
| 2016 | 6 Billion USD | 302.64% |
| 2015 | 1.49 Billion USD | 4.54% |
| 2014 | 1.42 Billion USD | 12.47% |
| 2013 | 1.26 Billion USD | -31.62% |
| 2012 | 1.85 Billion USD | 27.39% |
| 2011 | 1.45 Billion USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 11.94 Billion USD | 1.87% |
| 2024 Q2 | 11.9 Billion USD | -3.18% |
| 2024 Q1 | 12.29 Billion USD | -4.35% |
| 2023 Q2 | 12.63 Billion USD | 5.86% |
| 2023 Q3 | 12.62 Billion USD | -0.1% |
| 2023 Q4 | 12.85 Billion USD | 1.83% |
| 2023 FY | 12.85 Billion USD | 8.99% |
| 2023 Q1 | 11.93 Billion USD | 1.2% |
| 2022 Q1 | 11.56 Billion USD | 4.41% |
| 2022 FY | 11.79 Billion USD | 6.53% |
| 2022 Q2 | 11.62 Billion USD | 0.55% |
| 2022 Q4 | 11.79 Billion USD | 3.66% |
| 2022 Q3 | 11.37 Billion USD | -2.11% |
| 2021 Q3 | 11.02 Billion USD | 1.85% |
| 2021 Q2 | 10.82 Billion USD | 5.32% |
| 2021 Q1 | 10.27 Billion USD | -7.32% |
| 2021 FY | 11.07 Billion USD | -0.16% |
| 2021 Q4 | 11.07 Billion USD | 0.43% |
| 2020 Q4 | 11.09 Billion USD | -1.53% |
| 2020 FY | 11.09 Billion USD | -1.02% |
| 2020 Q1 | 11.47 Billion USD | 2.39% |
| 2020 Q2 | 11.4 Billion USD | -0.63% |
| 2020 Q3 | 11.26 Billion USD | -1.21% |
| 2019 Q2 | 10.85 Billion USD | 1.0% |
| 2019 Q3 | 11.07 Billion USD | 1.96% |
| 2019 Q1 | 10.75 Billion USD | 6.29% |
| 2019 FY | 11.2 Billion USD | 10.76% |
| 2019 Q4 | 11.2 Billion USD | 1.19% |
| 2018 Q2 | 9.84 Billion USD | 3.83% |
| 2018 FY | 10.11 Billion USD | 9.17% |
| 2018 Q4 | 10.11 Billion USD | 3.31% |
| 2018 Q3 | 9.79 Billion USD | -0.58% |
| 2018 Q1 | 9.48 Billion USD | 2.37% |
| 2017 Q1 | 7.48 Billion USD | 24.68% |
| 2017 FY | 9.26 Billion USD | 54.38% |
| 2017 Q4 | 9.26 Billion USD | 7.11% |
| 2017 Q3 | 8.65 Billion USD | 7.47% |
| 2017 Q2 | 8.05 Billion USD | 7.58% |
| 2016 FY | 6 Billion USD | 302.64% |
| 2016 Q4 | 6 Billion USD | 389.58% |
| 2016 Q3 | 1.22 Billion USD | -17.76% |
| 2016 Q2 | 1.49 Billion USD | 6.18% |
| 2016 Q1 | 1.4 Billion USD | -5.82% |
| 2015 Q3 | 1.39 Billion USD | -17.15% |
| 2015 Q2 | 1.68 Billion USD | 11.27% |
| 2015 Q1 | 1.51 Billion USD | 6.25% |
| 2015 FY | 1.49 Billion USD | 4.54% |
| 2015 Q4 | 1.49 Billion USD | 6.72% |
| 2014 Q2 | 1.41 Billion USD | 8.1% |
| 2014 Q3 | 1.39 Billion USD | -0.92% |
| 2014 Q1 | 1.3 Billion USD | 2.96% |
| 2014 FY | 1.42 Billion USD | 12.47% |
| 2014 Q4 | 1.42 Billion USD | 1.98% |
| 2013 Q3 | 1.43 Billion USD | -1.59% |
| 2013 FY | 1.26 Billion USD | -31.62% |
| 2013 Q2 | 1.45 Billion USD | -24.58% |
| 2013 Q1 | 1.93 Billion USD | 4.37% |
| 2013 Q4 | 1.26 Billion USD | -11.73% |
| 2012 FY | 1.85 Billion USD | 27.39% |
| 2012 Q4 | 1.85 Billion USD | 0.0% |
| 2011 FY | 1.45 Billion USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.14 Billion USD | -1022.707% |
| Charles River Laboratories International, Inc. | 2.78 Billion USD | -360.817% |
| Quest Diagnostics Incorporated | 4.68 Billion USD | -174.504% |
| Danaher Corporation | 13.67 Billion USD | 5.976% |
| Enzo Biochem, Inc. | -52.1 Million USD | 24770.863% |
| Laboratory Corporation of America Holdings | 5.41 Billion USD | -137.291% |
| Mettler-Toledo International Inc. | 2.01 Billion USD | -539.224% |
| Qiagen N.V. | 943.04 Million USD | -1263.143% |
| Revvity, Inc. | 3.11 Billion USD | -312.281% |
| Thermo Fisher Scientific Inc. | 26.84 Billion USD | 52.105% |
| Waters Corporation | 1.96 Billion USD | -555.721% |